Top brokers name 3 ASX shares to sell next week

Brokers aren't feeling overly positive on these shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that investors might want to hear about are summarised below. Here's why top brokers think investors ought to sell these shares next week:

Keyboard button with the word sell on it, symbolising the time being right to sell ASX stocks.

Image source: Getty Images

A2 Milk Company Ltd (ASX: A2M)

According to a note out of Citi, its analysts have downgraded this struggling infant formula company's shares to a sell rating and slashed their price target on them to $4.80. Citi has a number of concerns which it appears to believe have shifted the risks to the downside. These include supply disruption in China following lockdowns, weak pricing on Chinese ecommerce reseller platforms, and delays with its SAMR re-registration. Citi notes that the latter is far from guaranteed and could materially impact its sales should it not be granted. The A2 Milk share price is trading at $5.04 on Sunday.

IGO Ltd (ASX: IGO)

A note out of UBS reveals that its analysts have initiated coverage on this battery materials miner's shares with a sell rating and $12.65 price target. Although UBS notes that IGO provides investors with exposure to an attractive area of the resources sector, it isn't enough for a more positive rating. This is due to concerns over its current valuation. In addition, UBS fears that current lithium and nickel prices are unsustainable. The IGO share price was fetching $13.68 at Friday's close.

Magellan Financial Group Ltd (ASX: MFG)

Analysts at Macquarie have retained their underperform rating but lifted their price target on this fund manager's shares to $13.25. This follows the release of Magellan's latest funds under management update. While Macquarie was pleased to see Magellan's fund outflows slow, it thinks it may be too soon to get excited. The broker isn't expecting the outflows to stop any time soon. Particularly given the poor investment performance of its funds. The Magellan share price ended the week at $16.95.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk and Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

Macquarie shares: Buy, hold or sell?

Two top analysts offer their outlook for Macquarie’s outperforming shares.

Read more »

A steel worker peers out from under his protective headwear which is tipped back on his head as he stares solemnly straight ahead with steel production equipment in the background.
Broker Notes

Bell Potter says this beaten-down ASX materials stock can rise 56%

Down 17% this year, Bell Potter says ASX materials stock has significant upside.

Read more »

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Broker Notes

This ASX small-cap is tipped to almost double in the next year

Bell Potter just raised its guidance on this ASX small-cap.

Read more »

Man sits smiling at a computer showing graphs.
Broker Notes

6 ASX 200 shares with strengthened buy ratings this week

Brokers have maintained confidence in these ASX 200 stocks amid today's volatile market conditions.

Read more »

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans says hold BHP shares and buy this ASX 200 stock      

Let's see what the broker is saying about these stocks this week.

Read more »

An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements
Broker Notes

3 ASX 200 shares just upgraded to strong buy — here's what the brokers are saying

Do any of these ASX 200 stocks appeal to you?

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »